Matches in Wikidata for { <http://www.wikidata.org/entity/Q97461892> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q97461892 description "clinical trial" @default.
- Q97461892 description "ensayo clínico" @default.
- Q97461892 description "ensayu clínicu" @default.
- Q97461892 description "klinisch onderzoek" @default.
- Q97461892 description "клінічне випробування" @default.
- Q97461892 description "临床试验" @default.
- Q97461892 name "Safety, Tolerability, Pharmacodynamics and Pharmacokinetics, and Efficacy of CLTX-305 in Autosomal Dominant Hypocalcemia Type 1 (ADH1)" @default.
- Q97461892 name "Safety, Tolerability, Pharmacodynamics and Pharmacokinetics, and Efficacy of CLTX-305 in Autosomal Dominant Hypocalcemia Type 1 (ADH1)" @default.
- Q97461892 type Item @default.
- Q97461892 label "Safety, Tolerability, Pharmacodynamics and Pharmacokinetics, and Efficacy of CLTX-305 in Autosomal Dominant Hypocalcemia Type 1 (ADH1)" @default.
- Q97461892 label "Safety, Tolerability, Pharmacodynamics and Pharmacokinetics, and Efficacy of CLTX-305 in Autosomal Dominant Hypocalcemia Type 1 (ADH1)" @default.
- Q97461892 prefLabel "Safety, Tolerability, Pharmacodynamics and Pharmacokinetics, and Efficacy of CLTX-305 in Autosomal Dominant Hypocalcemia Type 1 (ADH1)" @default.
- Q97461892 prefLabel "Safety, Tolerability, Pharmacodynamics and Pharmacokinetics, and Efficacy of CLTX-305 in Autosomal Dominant Hypocalcemia Type 1 (ADH1)" @default.
- Q97461892 P1050 Q97461892-D73BD32B-1281-48AA-B814-8CFD9FCCBC5C @default.
- Q97461892 P1132 Q97461892-669EDA02-0240-4CC2-B76E-48A889D33AA7 @default.
- Q97461892 P1476 Q97461892-668B607D-5D9D-48D5-9482-71B72B796C23 @default.
- Q97461892 P17 Q97461892-66D36BCE-9A85-4C30-B261-A105EC38F6E0 @default.
- Q97461892 P2899 Q97461892-D1F29F26-32DE-4E26-A6BF-B8A84BE62A58 @default.
- Q97461892 P3098 Q97461892-A84690F6-2D97-4402-9ECC-97819BC91986 @default.
- Q97461892 P31 Q97461892-09976DFD-99F7-4116-8757-025CCF1E3B6D @default.
- Q97461892 P580 Q97461892-35946C4C-8F49-4989-AC70-653EF0FBF5EB @default.
- Q97461892 P582 Q97461892-D229DCD5-1DA4-4F4B-8907-93371A863920 @default.
- Q97461892 P6099 Q97461892-F0BF63F6-CE8F-4008-A1FC-A6E4F75B06C1 @default.
- Q97461892 P8005 Q97461892-1240D38E-8CF8-4B95-A054-9AC943A4C9C7 @default.
- Q97461892 P8363 Q97461892-2F58F516-F4F7-4288-9966-C9EF1C98EB43 @default.
- Q97461892 P1050 Q1586088 @default.
- Q97461892 P1132 "+20" @default.
- Q97461892 P1476 "A Phase IIb, Open-label Dose-ranging Study Evaluating the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics, and Efficacy of CLTX Hypocalcemia Type l (ADHl)." @default.
- Q97461892 P17 Q30 @default.
- Q97461892 P2899 "+16" @default.
- Q97461892 P3098 "NCT04465227" @default.
- Q97461892 P31 Q30612 @default.
- Q97461892 P580 "2020-07-15T00:00:00Z" @default.
- Q97461892 P582 "2021-09-01T00:00:00Z" @default.
- Q97461892 P6099 Q42824440 @default.
- Q97461892 P8005 Q76649614 @default.
- Q97461892 P8363 Q78089383 @default.